Lipid Systems is an innovative pharmaceutical company that has a unique, patented LNP (lipid nano particles) technology platform. Created by Prof Marek Langner and Magdalena Przybylo PhD utilizes their 15 year experience in biophysics of lipid formulations. GMP approved facility and R&D laboratories enables to develop novel formulations of the drugs and solve some of the unmet medical needs in the therapy.
Highly qualified team of Lipid Systems provides the company with dynamic development based on a wide range of competences, starting from LNP research, upscaling through pilot batches to full manufacturing.
Apart from using our own know-how, we develop new projects establishing long-term cooperation with modern research centers and partners around the world. Strong IP protection of the technology is the key for sustainable growth in the future.